Burling Wealth Partners LLC Buys Shares of 25,377 Danaher Co. (NYSE:DHR)

Burling Wealth Partners LLC acquired a new stake in shares of Danaher Co. (NYSE:DHR - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 25,377 shares of the conglomerate's stock, valued at approximately $5,825,000. Danaher makes up 1.2% of Burling Wealth Partners LLC's investment portfolio, making the stock its 25th biggest holding.

Other institutional investors and hedge funds have also bought and sold shares of the company. Howard Capital Management Group LLC grew its stake in shares of Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate's stock worth $342,000 after acquiring an additional 48 shares during the period. Tudor Financial Inc. bought a new stake in shares of Danaher in the third quarter worth approximately $414,000. Anchor Investment Management LLC grew its stake in shares of Danaher by 1.3% in the third quarter. Anchor Investment Management LLC now owns 6,039 shares of the conglomerate's stock worth $1,679,000 after acquiring an additional 78 shares during the period. World Investment Advisors LLC grew its position in Danaher by 5.3% during the third quarter. World Investment Advisors LLC now owns 12,948 shares of the conglomerate's stock valued at $3,600,000 after buying an additional 648 shares during the period. Finally, Arvest Bank Trust Division bought a new stake in Danaher during the third quarter valued at approximately $254,000. 79.05% of the stock is currently owned by institutional investors.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business's stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is owned by insiders.

Analyst Ratings Changes

DHR has been the subject of several recent research reports. Barclays boosted their target price on shares of Danaher from $205.00 to $215.00 and gave the company an "overweight" rating in a research report on Tuesday, April 22nd. Robert W. Baird cut their target price on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Royal Bank of Canada restated an "outperform" rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Jefferies Financial Group cut their target price on shares of Danaher from $260.00 to $230.00 and set a "buy" rating for the company in a research report on Tuesday, April 22nd. Finally, Raymond James restated a "market perform" rating on shares of Danaher in a research report on Monday, February 3rd. Five equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, Danaher presently has a consensus rating of "Moderate Buy" and an average price target of $264.40.

Danaher Price Performance

Shares of DHR stock traded up $1.94 during mid-day trading on Tuesday, hitting $197.85. The company had a trading volume of 1,286,233 shares, compared to its average volume of 4,472,902. The company has a market capitalization of $141.60 billion, a P/E ratio of 37.47, a P/E/G ratio of 2.66 and a beta of 0.86. The stock's 50 day moving average price is $200.69 and its 200-day moving average price is $223.46. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. The company had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. Equities research analysts forecast that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 25th. Investors of record on Friday, March 28th were paid a dividend of $0.32 per share. This is an increase from Danaher's previous quarterly dividend of $0.27. The ex-dividend date of this dividend was Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a yield of 0.65%. Danaher's dividend payout ratio is presently 24.85%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.